JP2024502473A5 - - Google Patents
Info
- Publication number
- JP2024502473A5 JP2024502473A5 JP2023541528A JP2023541528A JP2024502473A5 JP 2024502473 A5 JP2024502473 A5 JP 2024502473A5 JP 2023541528 A JP2023541528 A JP 2023541528A JP 2023541528 A JP2023541528 A JP 2023541528A JP 2024502473 A5 JP2024502473 A5 JP 2024502473A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- independently selected
- substituted
- ring atoms
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135303P | 2021-01-08 | 2021-01-08 | |
| US63/135,303 | 2021-01-08 | ||
| PCT/US2022/011551 WO2022150549A1 (en) | 2021-01-08 | 2022-01-07 | Oxalamide compounds and compositions for treating conditions associated with sting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502473A JP2024502473A (ja) | 2024-01-19 |
| JP2024502473A5 true JP2024502473A5 (https=) | 2025-01-15 |
Family
ID=80123502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541528A Pending JP2024502473A (ja) | 2021-01-08 | 2022-01-07 | Ｓｔｉｎｇ活性に関連する状態を治療するためのオキサルアミド化合物および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240083879A1 (https=) |
| EP (1) | EP4274826A1 (https=) |
| JP (1) | JP2024502473A (https=) |
| CN (1) | CN116964045A (https=) |
| WO (1) | WO2022150549A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4274824A1 (en) | 2021-01-08 | 2023-11-15 | IFM Due, Inc. | Heterobicyclic compounds having an urea or analogue and their compositions for treating conditions associated with sting activity |
| IL310724A (en) | 2021-08-10 | 2024-04-01 | Ifm Due Inc | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH STING ACTIVITY |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| EP1558252B1 (en) * | 2002-08-02 | 2007-10-10 | Merck & Co., Inc. | Substituted furo [2,3-b]pyridine derivatives |
| MY169791A (en) * | 2008-10-22 | 2019-05-15 | Array Biopharma Inc | Substituted pyrazolo [1,5-a] pyrimidine compounds as trk kinase inhibitors |
| US8497285B2 (en) | 2010-12-03 | 2013-07-30 | The Trustees Of The University Of Pennsylvania | Therapy of autoimmune colitis using a TIP60 inhibitor |
| CA2944198C (en) * | 2013-04-26 | 2021-11-16 | Indiana University Research & Technology Corporation | Hydroxyindole carboxylic acid based inhibitors for oncogenic src homology-2 domain containing protein tyrosine phosphatase-2 (shp2) |
| CA2927009C (en) | 2013-10-21 | 2019-04-23 | Drexel University | Use of sting agonists to treat chronic hepatitis b virus infection |
| CN120004785A (zh) * | 2018-07-03 | 2025-05-16 | 诺华制药股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| WO2020236586A1 (en) * | 2019-05-17 | 2020-11-26 | Ifm Due, Inc. | N-hetaryl-squaramide compounds for treating conditions associated with sting activity |
| WO2021067791A1 (en) * | 2019-10-03 | 2021-04-08 | Ifm Due, Inc. | Oxalamide compounds and compositions for treating conditions associated with sting activity |
-
2022
- 2022-01-07 JP JP2023541528A patent/JP2024502473A/ja active Pending
- 2022-01-07 US US18/271,186 patent/US20240083879A1/en active Pending
- 2022-01-07 EP EP22701780.3A patent/EP4274826A1/en not_active Withdrawn
- 2022-01-07 WO PCT/US2022/011551 patent/WO2022150549A1/en not_active Ceased
- 2022-01-07 CN CN202280019954.XA patent/CN116964045A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502473A5 (https=) | ||
| JP2023509422A5 (https=) | ||
| JP2022536755A5 (https=) | ||
| JP2022550640A5 (https=) | ||
| JP2022535743A5 (https=) | ||
| HRP20171294T1 (hr) | Derivati fenilamid 4-(benzil)-piperazin-1-karboksilne kiseline i slični spojevi kao modulatori amidazne hidrolaze masne kiseline (faah) za liječenje tjeskobe, boli i drugih stanja | |
| JP2022544714A5 (https=) | ||
| JP2021105002A5 (https=) | ||
| JP2012507522A5 (https=) | ||
| WO2017160861A1 (en) | Inhibitors for soluble epoxide hydrolase (seh) and fatty acid amide hydrolase (faah) | |
| JP2004509855A (ja) | ＴＮＦαインヒビターとして有用なクマリン誘導体 | |
| JP2022538301A5 (https=) | ||
| RU2013150349A (ru) | 5-замещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов васе, содержащие их композиции и их применение | |
| RU2019129299A (ru) | Модуляторы глюкокортикоидного рецептора для лечения рака шейки матки | |
| JP2020517677A5 (https=) | ||
| CA2457444A1 (en) | 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity | |
| JP2021530560A5 (https=) | ||
| JP2024529527A5 (https=) | ||
| CN115175905A (zh) | Zeste增强子同源物2抑制剂及其用途 | |
| JP2019513745A5 (https=) | ||
| WO2021231726A1 (en) | Enpp1 modulators and uses thereof | |
| JP2020521766A5 (https=) | ||
| JP2017511383A5 (https=) | ||
| ES2525298T3 (es) | Compuestos heterocíclicos como agonistas del S1P1 para el tratamiento de enfermedades autoinmunes y vasculares | |
| JP2010520884A5 (https=) |